Production (Stage)
IGM Biosciences, Inc.
IGMS
$1.29
-$0.03-2.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 21.12% | -20.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.12% | -20.16% | |||
| Cost of Revenue | -11.65% | -49.57% | |||
| Gross Profit | 12.24% | 49.90% | |||
| SG&A Expenses | 523.66% | -90.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.95% | -61.44% | |||
| Operating Income | -26.03% | 61.77% | |||
| Income Before Tax | -44.33% | 40.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -44.33% | 40.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -44.33% | 40.34% | |||
| EBIT | -26.03% | 61.77% | |||
| EBITDA | -29.15% | 64.14% | |||
| EPS Basic | -43.58% | 40.53% | |||
| Normalized Basic EPS | 0.60% | 52.67% | |||
| EPS Diluted | -43.58% | 40.53% | |||
| Normalized Diluted EPS | 0.60% | 52.67% | |||
| Average Basic Shares Outstanding | 0.52% | 0.32% | |||
| Average Diluted Shares Outstanding | 0.52% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||